As such, TgF344-AD rats display neuronal tau deposition in contrast to what is generally observed in transgenic mice with these particular gene mutations (Duyckaerts et al., 2008; Stancu et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.